This review outlines the molecular biology, therapeutic rationale, and administration recommendations for nesiritide in acute or advanced decompensated heart failure.
No takes yet. Share an insight, caveat, or question.
May guide nesiritide use in decompensated HF; leaves open need for contemporary outcome trials.
Zineh et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: